Top Markets
#1 ADO Protocol ADO Protocol +329.47%
#2 GoPlus Security GoPlus Security +54.27%
#3 Nockchain Nockchain +46.24%
#4 Tutorial Tutorial +35.05%
#5 Starpower Starpower +34.11%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.96%
#7 The Black Bull The Black Bull +31.29%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +21.33%
#10 Verus Coin Verus Coin +20.40%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
China Regenerative Medicine International Limited China Regenerative Medicine International Limited

China Regenerative Medicine International Limited

8158
Rang in aandelen #32811
China Regenerative Medicine International Limited operates as an investment... China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
Aandeelprijs
$0.02967889
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$9.03M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-72.68%
Land
HK
Handel China Regenerative Medicine International Limited (8158)

Categorie

Healthcare
Winst voor China Regenerative Medicine International Limited (8158)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van China Regenerative Medicine International Limited bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van China Regenerative Medicine International Limited van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE